Pediatr Infect Vaccine.
2022 Apr;29(1):1-15. 10.14776/piv.2022.29.e1.
Therapeutics in the Treatment of COVID-19 for Children and Adolescents
- Affiliations
-
- 1Department of Pediatrics, Pusan National University Hospital, Busan, the Republic of Korea
- 2Department of Pediatrics, Jeju National University School of Medicine, Jeju, the Republic of Korea
- 3Department of Pediatrics, Seoul National University College of Medicine, Seoul, the Republic of Korea
- KMID: 2529860
- DOI: http://doi.org/10.14776/piv.2022.29.e1
Abstract
- Coronavirus disease 2019 (COVID-19) presents as a mild-to-moderate respiratory illness in most children. However, a small proportion of children with COVID-19 develop severe or critical illnesses. Although pediatric clinical trials for the treatment of COVID-19 are sparse, some drugs are available for children and adolescents with severe COVID-19. This review summarizes clinical data focusing on antiviral agents and immunomodulators for use in treating COVID-19. In addition, current recommendations for therapeutics for children and adolescents with COVID-19 are discussed.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Therapeutics for the treatment of coronavirus disease 2019 in children and adolescents
- Kidney complications associated with COVID-19 infection and vaccination in children and adolescents: a brief review
- COVID-19 in immunocompromised children and adolescents
- The Effects of COVID-19 on the Self-Harm in Children and Adolescents Observed in a University Hospital
- Adverse reactions to coronavirus disease 2019 vaccines in children and adolescents
